Danaher Co. (DHR) Holdings Raised by Mn Services Vermogensbeheer B.V.

Mn Services Vermogensbeheer B.V. grew its stake in shares of Danaher Co. (NYSE:DHR) by 1.3% in the first quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 98,495 shares of the conglomerate’s stock after acquiring an additional 1,300 shares during the period. Mn Services Vermogensbeheer B.V.’s holdings in Danaher were worth $9,644,000 at the end of the most recent reporting period.

Several other institutional investors also recently added to or reduced their stakes in DHR. First Personal Financial Services grew its position in shares of Danaher by 128.9% during the 4th quarter. First Personal Financial Services now owns 1,227 shares of the conglomerate’s stock valued at $114,000 after acquiring an additional 691 shares during the period. Calton & Associates Inc. bought a new position in shares of Danaher during the 4th quarter valued at approximately $114,000. CNB Bank bought a new position in shares of Danaher during the 4th quarter valued at approximately $116,000. Truewealth LLC bought a new position in shares of Danaher during the 4th quarter valued at approximately $121,000. Finally, Zions Bancorporation bought a new position in shares of Danaher during the 1st quarter valued at approximately $123,000. 76.66% of the stock is owned by hedge funds and other institutional investors.

In other Danaher news, Director Linda P. Hefner sold 18,001 shares of the stock in a transaction that occurred on Thursday, April 26th. The shares were sold at an average price of $101.51, for a total value of $1,827,281.51. Following the sale, the director now directly owns 25,225 shares in the company, valued at approximately $2,560,589.75. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Daniel L. Comas sold 78,379 shares of the stock in a transaction that occurred on Monday, April 23rd. The stock was sold at an average price of $101.67, for a total transaction of $7,968,792.93. Following the completion of the sale, the chief financial officer now owns 148,769 shares in the company, valued at $15,125,344.23. The disclosure for this sale can be found here. Insiders have sold a total of 256,499 shares of company stock worth $25,987,197 over the last 90 days. 11.90% of the stock is currently owned by corporate insiders.

Shares of DHR stock opened at $102.13 on Friday. The company has a market cap of $71.35 billion, a P/E ratio of 24.49, a price-to-earnings-growth ratio of 1.91 and a beta of 1.03. The company has a debt-to-equity ratio of 0.38, a quick ratio of 1.15 and a current ratio of 1.59. Danaher Co. has a 12 month low of $78.97 and a 12 month high of $104.82.

Danaher (NYSE:DHR) last announced its quarterly earnings results on Thursday, April 19th. The conglomerate reported $0.99 EPS for the quarter, beating the Zacks’ consensus estimate of $0.94 by $0.05. The company had revenue of $4.70 billion for the quarter, compared to analysts’ expectations of $4.54 billion. Danaher had a net margin of 13.56% and a return on equity of 11.39%. Danaher’s revenue was up 11.6% compared to the same quarter last year. During the same period in the prior year, the company posted $0.85 EPS. research analysts forecast that Danaher Co. will post 4.45 EPS for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Friday, July 27th. Investors of record on Friday, June 29th will be paid a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a dividend yield of 0.63%. The ex-dividend date of this dividend is Thursday, June 28th. Danaher’s payout ratio is currently 15.88%.

A number of research analysts have recently weighed in on the stock. Zacks Investment Research downgraded shares of Danaher from a “buy” rating to a “hold” rating in a research report on Friday. Barclays reissued a “buy” rating and set a $113.00 target price on shares of Danaher in a research report on Friday, April 20th. Morgan Stanley increased their target price on shares of Danaher from $112.00 to $113.00 and gave the company an “overweight” rating in a research report on Friday, April 20th. Robert W. Baird reissued a “buy” rating and set a $106.00 target price on shares of Danaher in a research report on Friday, April 20th. Finally, Jefferies Group reissued a “buy” rating and set a $117.00 target price on shares of Danaher in a research report on Friday, April 20th. One analyst has rated the stock with a sell rating, five have assigned a hold rating and fourteen have assigned a buy rating to the company’s stock. The company presently has an average rating of “Buy” and a consensus target price of $105.56.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides laser scanning, compound, surgical, and other stereo microscopes. This segment also offers filtration, separation, and purification technologies to the biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial sectors.

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply